| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $343K | +131.8% | -35.8% |
| Cost of Revenue | $276K | +97.1% | -7.1% |
| Gross Profit | $67K | +737.5% | -71.7% |
| R&D Expense | $1.4M | -21.7% | -27.9% |
| SG&A Expense | $2.1M | +0.4% | -1.4% |
| Operating Income | -$3.5M | +11.5% | +10.7% |
| Pre-tax Income | -$3.8M | +4.0% | -3.7% |
| Net Income | -$3.8M | +4.0% | -3.7% |
| EPS (Basic) | -$2.25 | +3.8% | -3.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.7M | — | — |
| Short-term Investments | $3.9M | -44.5% | -78.4% |
| Accounts Receivable | $504K | +278.9% | -2.3% |
| Current Assets | $11.3M | -21.0% | -53.9% |
| Total Assets | $16.2M | -17.9% | -41.2% |
| Current Liabilities | $1.8M | -3.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$11.2M | — | — |
| Capital Expenditures | $857K | — | — |
| Investing Cash Flow | $10.8M | — | — |
| Financing Cash Flow | -$80K | — | — |
| Free Cash Flow | -$12.0M | — | — |
| -26.4% |
| Total Liabilities | $4.0M | -3.8% | +46.6% |
| Stockholders' Equity | $12.2M | -21.7% | -50.9% |